G01N 33/6884
From lung
Official title: {from lung}
G01N33/6884 (From lung) appears on 63 US grants and 140 published applications in this corpus.
Search patents in G01N- Granted patents
- 63
- Published applications
- 140
- Assignees
- 97
- Inventors
- 328
- Latest grant
- 3 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 2 |
| 2003 | 0 | 2 |
| 2004 | 0 | 3 |
| 2005 | 0 | 2 |
| 2006 | 0 | 1 |
| 2007 | 2 | 2 |
| 2008 | 0 | 1 |
| 2009 | 1 | 3 |
| 2010 | 2 | 7 |
| 2011 | 2 | 7 |
| 2012 | 1 | 5 |
| 2013 | 5 | 16 |
| 2014 | 5 | 17 |
| 2015 | 4 | 13 |
| 2016 | 4 | 5 |
| 2017 | 6 | 8 |
| 2018 | 3 | 2 |
| 2019 | 4 | 6 |
| 2020 | 2 | 4 |
| 2021 | 4 | 1 |
| 2022 | 2 | 8 |
| 2023 | 2 | 3 |
| 2024 | 2 | 5 |
| 2025 | 2 | 7 |
| 2026 | 1 | 10 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Point of care device, method and kit involving club cell protein 16 as a marker for silicosis3 Mar 2026US 12,566,182 B2Indian Council of Medical Research
- Pulse stable tracer methods for detection of short-chain fatty acids18 Nov 2025US 12,474,352 B2
- Compositions and methods for detection and treatment of coronavirus infection11 Mar 2025US 12,247,978 B2Arizona Board of Regents On Behalf of Northern Arizona University
- Pulmonary hypertension biomarker18 Jun 2024US 12,012,636 B2Novartis AG
- Isolated human lung progenitor cells and uses thereof21 May 2024US 11,987,807 B2The General Hospital Corporation
- Molecular analysis of extracellular vesicles (evs) for the detection of idiopathic pulmonary fibrosis24 Sep 2026US 2026/0287595 A1The General Hospital Corporation
- Methods of monitoring splicing17 Sep 2026US 2026/0276651 A1Rage Biotech Pty Ltd
- CC16-HNE Assay10 Sep 2026US 2026/0266838 A1Nordic Bioscience A/S
- Method for measuring pulmonary surfactant protein d, measurement kit, monoclonal antibody, and cell6 Aug 2026US 2026/0227394 A1Sekisui Medical Co., Ltd.
- Methods for prognosis and monitoring pulmonary hypertension23 Jul 2026US 2026/0210973 A1Assistance Publique-HôPitaux De Paris (Aphp)
Most cited
By later US patents
- Isothiazolopyridinones useful for the treatment of (inter alia) cystic fibrosis63US 8,802,844 B2Vertex Pharmaceuticals Incorporated · 2014
- Isothiazolopyridinones useful for the treatment of (inter alia) cystic fibrosis42US 9,399,648 B2Vertex Pharmaceuticals Incorporated · 2016
- Methods of identifying lung homing molecules using membrane dipeptidase27US 6,174,687 B1The Burnham Institute · 2001
- SAP-6-Val proteins and methods20US 5,013,720 AAbbott Laboratories · 1991
- Monoclonal antibodies against alveolar surfactant protein19US 4,656,253 ACalifornia Biotechology, Inc. · 1987